Maybe this got missed in all the news today.
I did a similar thing when I took on the CSO role and got paid in options back in 2019 - $140k in salary became a bit over $5.5 million worth of shares by the time of conversion. But what would I know about the value of Race so take no notice of what I am doing and just follow the herd - the market always get biotech valuations right as everyone knows.
Ann: Dr Daniel Tillett appointed CEO of Race Oncology, page-66
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |